Major Categories of Liver Disease
Liver diseases can be systematically organized into six major categories: viral hepatitis, metabolic/steatotic liver disease, alcohol-related liver disease, autoimmune/immune-mediated diseases, drug/toxin-induced injury, and vascular disorders 1.
Primary Disease Categories
1. Viral Hepatitis
The viral hepatitis category encompasses infections that directly target hepatocytes:
- Hepatitis B (HBV) ± Hepatitis D (HDV): Identified by HBsAg positivity, with HDV requiring HBV co-infection 1
- Hepatitis C (HCV): Diagnosed by HCV RNA positivity 1
- Acute viral hepatitis: Including hepatitis A (HAV), hepatitis E (HEV), Epstein-Barr virus (EBV), and cytomegalovirus (CMV) - typically self-limited in immunocompetent individuals 1
These infections account for approximately one million deaths annually worldwide and remain leading causes of cirrhosis and hepatocellular carcinoma globally 2, 3.
2. Steatotic Liver Disease (SLD)
This represents the most common liver disease category in developed nations, affecting 20-30% of the general population 4:
- Metabolic dysfunction-associated SLD (MASLD): Previously termed nonalcoholic fatty liver disease (NAFLD), driven by obesity, diabetes, and metabolic syndrome 1
- Metabolic dysfunction-associated steatohepatitis (MASH): The progressive inflammatory form occurring in 25-30% of MASLD cases, with risk of fibrosis and cirrhosis 4
- Alcohol-related liver disease: Caused by alcohol intake exceeding 2 standard drinks/day for women or 3 standard drinks/day for men (10g alcohol = 1 standard drink) 1
The AST:ALT ratio helps distinguish etiologies: typically >2 in alcohol-related disease and <1 in metabolic disease 4.
3. Immune-Mediated Liver Diseases
These autoimmune conditions require specific serological and histological diagnosis 1, 5:
Autoimmune hepatitis (AIH): Characterized by elevated aminotransferases, hypergammaglobulinemia, and specific autoantibodies
- AIH-1: ANA and/or SMA positive (most common, 90% of cases)
- AIH-2: Anti-LKM1 or anti-LC1 positive (10% of cases, typically more severe, often in children)
- AIH-3: Anti-SLA/LP positive (similar to AIH-1, possibly more severe) 5
Primary biliary cholangitis (PBC): Cholestatic pattern with anti-mitochondrial antibodies 5
Primary sclerosing cholangitis (PSC): Cholestatic disease with bile duct stricturing, strongly associated with inflammatory bowel disease (prevalence ~10% in IBD patients) 1, 6
IgG4-associated cholangitis: Mimics PSC but responds to immunosuppression 5
4. Drug-Induced and Toxic Liver Injury
This increasingly recognized category includes 1, 7:
- Idiosyncratic drug-induced liver injury (DILI): Unpredictable reactions to medications including carbamazepine, methyldopa, minocycline, macrolide antibiotics, nitrofurantoin, statins, sulfonamides, terbinafine, and methotrexate 6
- Herbal and dietary supplements: Growing cause of hepatotoxicity 1
- Occupational exposures: Solvents, pesticides, metals, and industrial chemicals causing toxicant-associated steatohepatitis (TASH) 7
5. Hereditary Metabolic Disorders
Genetic conditions affecting liver metabolism 1, 8:
- Hemochromatosis: Iron overload disorder
- Wilson disease: Copper metabolism defect
- Alpha-1 antitrypsin deficiency: Protein misfolding disorder
- Glycogen storage diseases: Particularly type IV
- Hereditary tyrosinemia: Amino acid metabolism disorder
6. Vascular Liver Diseases
Disorders affecting hepatic blood flow 1, 9:
- Budd-Chiari syndrome: Hepatic venous outflow obstruction
- Portal vein thrombosis: With or without underlying cirrhosis
- Sinusoidal obstruction syndrome: Previously called veno-occlusive disease
- Portosinusoidal vascular disorder: Non-cirrhotic portal hypertension
- Ischemic hepatitis: Acute hypoperfusion injury
Critical Clinical Considerations
When evaluating unexplained liver test abnormalities, systematically exclude the most common causes first: Begin with MASLD and alcohol exposure screening, then viral hepatitis serologies (HBV, HCV), followed by autoimmune markers if cholestatic or hepatocellular patterns persist 1.
The pattern of liver enzyme elevation guides differential diagnosis 4:
- Hepatocellular pattern (ALT/AST predominant): Consider viral hepatitis, MASLD, alcohol, autoimmune hepatitis, drug injury
- Cholestatic pattern (ALP/GGT predominant): Consider PBC, PSC, IgG4 cholangitis, drug injury
Common diagnostic pitfall: Patients with resolved viral hepatitis (HCV antibody-positive but RNA-negative, or HBsAg-negative with HBcAb-positive) remain at risk for advanced liver disease from other causes and require continued screening for metabolic syndrome, alcohol exposure, and signs of cirrhosis 1.
Referral to hepatology is warranted when initial screening fails to identify etiology, when immune-mediated disease is suspected, for management of active viral hepatitis, or when any signs of advanced fibrosis/cirrhosis are present 1.